Shopping cart
Is Liver Transplantation Advisable for Isoniazid Fulminant Hepatitis in Active Extrapulmonary Tuberculosis?
Authors: Barcena, Rafael; Oton, Elena1; Moreno, Maria Angeles2; Fortún, Jesús3; Garcia-Gonzalez, Miguel1; Moreno, Ana3; de Vicente, Emilio4
Source: American Journal of Transplantation, Volume 5, Number 11, November 2005 , pp. 2796-2798(3)
Publisher: Wiley-Blackwell
Abstract:
Antituberculous treatment is a well-known cause of fulminant hepatic failure (FHF). This could lead to liver transplantation as the only possible treatment, which on the other hand could be contraindicated due to active tuberculosis. The risk of aggressive dissemination of the disease after transplantation is not clearly determined by the current second-line antituberculous therapies. We report a case of vertebral tuberculosis treated with rifampin, isoniazid and pyrazinamide. He developed an FHF that was treated with urgent liver transplantation. Despite the immunosuppression, the disease was well controlled with ciprofloxacin, ethambutol and streptomycin and the patient is in good health 23 months after transplantation. In conclusion, active extrapulmonary tuberculosis should perhaps be considered for liver transplantation when FHF develops due to anti-tuberculous drugs.Keywords: Infection; liver failure; liver transplantation; toxicity
Document Type: Research article
DOI: http://dx.doi.org/10.1111/j.1600-6143.2005.01065.x
Affiliations: 1: Hepato-Gastroenterology Service 2: Internal Medicine Service 3: Infectious diseases Service 4: General Surgery Service, Ramon y Cajal Hospital, Madrid, Spain
Publication date: 2005-11-01
- In this: publication
- By this: publisher
- In this Subject: Microbiology , Allergy & Immunology , Medicine (General) , Surgery
- By this author: Barcena, Rafael ; Oton, Elena ; Moreno, Maria Angeles ; Fortún, Jesús ; Garcia-Gonzalez, Miguel ; Moreno, Ana ; de Vicente, Emilio
Tools
Receive new issue alert
Latest TOC RSS Feed
Get PermissionsKey
Print this page